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Abstract
Background: During pregnancy, women are more susceptible to Plasmodium falciparum infections
and frequently have a higher parasitaemia than non-pregnant women. Several mechanisms are
responsible for their increased susceptibility, including down-modulation of immune responses that
aid in parasite clearance and sequestration of infected erythrocytes in the placenta. Early in
pregnancy, a third mechanism may contribute to higher parasitaemia, since it has been reported
that addition of human chorionic gonadotropin (hCG) to in vitro cultures of the NF54-strain of P.
falciparum results in increased parasite growth rates. The goal of this study was to further examine
the effect of hCG on P. falciparum growth.
Methods: The NF54-3D7, FVO and 7G8 strains of P. falciparum were cultured in vitro with various
physiological concentrations of hCG purchased from three sources. Infected erythrocytes were
also co-cultured with a human cell line that naturally secretes hCG.
Results:  Results from 14 experiments using different combinations of parasite strains and
concentrations of hCG from different sources, as well as the co-culture studies, failed to provide
convincing evidence that hCG enhances parasite growth in vitro.
Conclusion: Based on these data, it seems unlikely that hCG has a direct effect on the rate of
parasite growth early in pregnancy.
Background
Women, especially primigravidae, are more susceptible to
the harmful effects of Plasmodium falciparum infections
during pregnancy than non-pregnant women [1,2]. They
are more likely to be slide-positive for malaria, have a
higher parasitaemia, and develop anaemia. As a result,
pregnant women are at an increased risk of clinical illness
and poor pregnancy outcomes. A combination of factors
contributes to higher parasitaemia and severity of disease.
Physiological and immunological changes that occur dur-
ing pregnancy alter immune responses that aid in parasite
killing [3-5] and infected erythrocytes (IE) reach high
numbers in the intervillous space (IVS) of the placenta
due to sequestration [6]. A third possible reason for high
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parasitaemia was suggested by Rohrig et al, who found
that the pregnancy-associated hormone, human chori-
onic gonadotropin (hCG) increased the growth rate of P.
falciparum in vitro [7]. This finding has lead to the specula-
tion that P. falciparum parasites may grow at a faster rate in
vivo during the early part of pregnancy. A large number of
studies have confirmed the importance of the first two
mechanisms, but studies confirming the influence of hCG
have not been reported.
A role for hCG in enhancing parasitaemia during preg-
nancy seems plausible. It is produced by syncytiotrophob-
lasts, the cell type that lines the IVS where high
parasitaemias are found. hCG is released into the blood
starting early following conception, reaches peak concen-
trations between 8 to 12 weeks of gestation, and then
decreases to low levels by the early part of the second tri-
mester [8]. The peak of hCG immediately precedes the
period when women are reported to be the most suscepti-
ble to malaria. In surveying the literature, Brabin found
that in many studies the period of highest prevalence of
malaria and parasitaemia was during the 13–16 weeks of
pregnancy [1]. Recently, a large-scale study found that
hCG levels are slightly higher in primigravidae, the popu-
lation of women most susceptible to malaria, and that
hCG levels decrease with gravidity [9]. Thus, current data
are consistent with the possibility that hCG enhances par-
asitaemia during pregnancy.
The purpose of this study was to further evaluate the effect
of hCG on P. falciparum growth in vitro. In the sentinel
study, hCG was purchased from Ferring (Germany) and
added to cultures of the NF54 strain of P. falciparum.
Unfortunately, hCG from this source was no longer avail-
able when we conducted the study. Previous studies have
shown that significant differences in the composition and
levels of contaminating bioactive molecules exist among
commercial preparations of hCG [10,11]. For example,
some of the properties initially ascribed to hCG were later
found to be due to contaminating Epithelial Growth Fac-
tor [11] and serine proteases [12]. Therefore, in the cur-
rent study purified hCG from three suppliers were used
and their composition was compared by SDS-PAGE. In
addition, IE were co-cultured directly with a human cell
line (BeWo) that secretes hCG [13]. To determine if hCG
enhanced the growth rate of IE in general, three strains of
P. falciparum were employed, including NF54-3D7, FVO
originally isolated from south-east Asia that has been
maintained in long-term culture, and the 7G8 strains
which is a fast-growing, chloroquine-resistant strain.
Results from the in vitro studies using various combina-
tions of parasite strains and sources of purified hCG (n =
14 experiments) failed to provide convincing evidence
that hCG enhances the growth rate of P. falciparum in vitro.
Methods
Sources of hCG
HCG was purchased from the following companies.
Sigma: Chorionic gonadotropin human, product number
CG5, that contains approximately 5,000 IU/vial (Sigma,
St. Louis, MO); Calbiochem, hCG: purified from human
urine, standard grade, catalog number 230734, which
contained ~3,000 IU hCG/ml based on the WHO stand-
ard IRP75/551 (Calbiochem.com); and Cell Sciences,
Inc.: ultra pure, catalog number CRC101B, purified by a
proprietary chromatographic technique containing 3,559
and 5,000 IU/ml based on IRP reference 75/551 (Cell Sci-
ences, Inc., Canton, MA). Lyophilized hCG was reconsti-
tuted in ddH20 as recommended by the manufacturers
and then diluted in complete culture medium (see
below).
In vitro culture of P. falciparum
Plasmodium falciparum of the NF54-3D7, FVO and 7G8
strains were maintained in continuous in vitro cultures
based on the method of Trager and Jensen [14]. Parasites
were cultured in A+ RBC at a 5% haematocrit in RPMI-
1640 supplemented with 4.5g/L of D-glucose, 2.383 g/L
of HEPES, 0.02 mg/mL of hypoxanthine, 1.5g/L of
sodium bicarbonate, 0.11 g/L of sodium pyruvate, and
0.5% Albumax II (Gibco, Invitrogen). Parasites were
grown in 96-well microtiter plates at 37°C in the presence
of 5% CO2, 5% O2 and 90% N2.
Fourteen in vitro experiments were conducted using the
3D7 and FVO strains of P. falciparum. Triplicate microtiter
wells were seeded with ~0.5% parasitaemia in the absence
of hCG (control) or with two-fold serial concentrations of
hCG ranging from 12.5 to 200 IU hCG/ml. These levels
reflect those used in the original publication [7] and are
equal to physiological levels in pregnant women. HCG
concentrations in peripheral blood reach peak concentra-
tions ~25,000–280,000 mIU hCG/ml (depending on the
assay system) and gradually decline to ~3,000–20,000
mIU/ml for the remainder of pregnancy, [[7,8], product
inserts]. Every 24 hrs, culture medium was changed and
new medium containing hCG was added. HCG from
Sigma was used in three experiments, from Calbiochem in
six experiments, and from Cell Sciences Inc. in five exper-
iments. To determine parasitaemia, either aliquots were
collected every other day or sets of triplicate wells were
harvested.
Determining parasitaemia
In eight experiments, thin blood films were prepared,
stained with Diff-Quick (IMEB Inc., San Marcos, CA). Per-
cent parasitaemia was determined by two microscopists
who examined coded smears and counted the number of
IE per 500 to 1,000 RBC. In the remaining six experi-
ments, cells were treated with 2 μl of 5 mM Vybrant Dye-Malaria Journal 2009, 8:101 http://www.malariajournal.com/content/8/1/101
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Cycle™ Stain per 106 cells (Molecular Probes, Invitrogen)
and the number of IE per 500,000 RBC was determined by
flow cytometry using a FACSaria (Beckin-Deckinson).
Co-culturing P. falciparum with BeWo cells
BeWo cells are a human choriocarcinoma cell line [13].
When treated with forskolin, they form syncytia with
characteristics of syncytiotrophoblasts (BeWo-ST) and
secrete hCG plus a variety of cytokines and hormones
[13,15]. The BeWo-IE co-culture system was optimized
prior to use. BeWo cells were cultured in HAM's F 12 com-
plete medium supplemented with 2 mM L-glutamine,
100 units/mL of penicillin, 100 μg/mL of streptomycin,
and 10% FBS. Prior to each experiment, 2.5 × 104 cells/ml
were seeded in each well of a 48-well microtiter plate.
After 24 h, the cells were induced with 40 μM of forskolin
(Sigma, USA) for 48 hrs using FBS-free medium that was
changed daily, and then cultured for 24 h in complete
medium before the experiment. Microscopic examination
of cell morphology and monitoring of hCG production
were indicative of BeWo transformation into syncytia.
The parasitaemia was adjusted to the levels specified in
the text. Then, an aliquot was either cultured in parasite
culture medium as described above, or an equal volume
of the IE was added to the monolayer of BeWo-ST cells in
triplicate. Co-cultures were incubated at 37°C, with 5%
CO2, 5% O2, and 90% N2. IE were harvested from the
individual wells, stained with Vybrant DyeCycle™, and
examined by flow cytometry.
Measurement of hCG in co-cultures
The concentration of hCG in BeWo culture supernatants
was determined using the Human Chorionic Gonadotro-
pin-Beta Micro-ELISA Test kit (T108) and the accompany-
ing hCG standards from Leinco Technologies (St. Louis,
MO).
SDS-PAGE analysis of commercial hCG
hCG from the three sources were analysed by SDS-PAGE
according to Laemmli [16]. Ten μg of protein, based on
protein concentration provided by the manufacturer, was
added to reducing buffer, heated at 100°C for 5 minutes,
and electrophoresed on pre-prepared Invitrogen Novex
Bis-Tris 4–12% gels (Invitrogen, Carlsbad, CA). SeeBlue
Plus2 pre-stained standards were used and gels were
stained with Simply Blue Coomassie stain (both from Inv-
itrogen).
Data analysis
Percent parasitaemia, determined either by slide or FACS,
was summarized by geometric means and geometric
standard errors and pair-wise comparisons were per-
formed between different concentrations of hCG and
absence of hCG using Student's t test. The percent parasi-
taemia from IE, when cultured alone or with BeWo cells,
was compared using analysis of variance (ANOVA)
adjusted by Tukey's rule.
Results
SDS-PAGE analysis of commercial hCG
The three commercial sources of hCG were compared by
SDS-PAGE under reducing conditions. Since hCG is a
glycoprotein with multiple glycosylation sites, including
two in the alpha chain (MW 14.5 kDa) and four in the
beta chain (MW 22.2)], the subunits do not run accurately
on SDS-PAGE [17]. Results show that hCG from Sigma
and Calbiochem consisted primarily of the alpha and
beta-chains of hCG, whereas additional bands were
present in the preparation from Cell Sciences, Inc. (Figure
1).
Influence of hCG on in vitro growth of P. falciparum
In eight experiments, the 3D7 and FVO strains of P. falci-
parum were cultured with various concentrations of hCG
and parasitaemia was assessed by microscopy. Compari-
son of the results reveals no difference between cultures
supplemented with hCG from the three difference
sources, so the results for each parasite strain were aver-
aged. Overall, during the first three days of in vitro culture,
average parasitaemia in cultures without hCG rose from
SDS-PAGE of hCG used in the study Figure 1
SDS-PAGE of hCG used in the study. The lanes contain: 
1) molecular weight pre-stained standards, 2) hCG from 
Sigma Aldrich, 3) Calbiochem, 4) Cell Sciences, Inc., and 5) 
molecular weight standards. Arrows indicate location of the 
β- and α-chains of hCG.
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0.5% on Day 0 to 2.4% (3D7) and 3.2% (FVO) on Day 3,
and then the growth of FVO slowed slightly (Figure 2A
and 2B, respectively). No significant difference in parasite
growth was found in cultures supplemented with increas-
ing concentrations of hCG (12.5 – 200 IU/ml) compared
to that in the absence of hCG on Day 1, 3, and 5, (all pair-
wise p values were > 0.05 using Student's t-test). There-
fore, the addition of 12.5 to 200 IU/ml of hCG to parasite
cultures neither enhanced nor suppressed parasite growth
in vitro based on microscopic assessment of parasitaemia.
Since parasitaemia based on microscopy can produce var-
iable results especially with low parasitaemia, the study
was repeated using flow cytometry where the number of
IE per 500,000 RBC was determined (Figure 3). In addi-
tion, in the same experiment cultures of NF54-3D7 and
FVO were supplemented with hCG from CellSciences,
Sigma-Aldrich, and Calbiochem (Figure 3). Starting para-
sitaemia of 0.5% increased to 4.1% for 3D7 and 10% for
FVO during the period of culture. The higher parasitaemia
in these cultures compared to those in Figure 2 reflects the
improved accuracy of flow cytometry in estimating parasi-
taemia compared to microscopy. No difference was found
in parasitaemia when NF54-3D7 and FVO (Figure 3) par-
asites were cultured with 12.5 to100 IU hCG/ml from
each of the three sources (P > 0.05 in all pair-wise compar-
isons).
Co-culture of P. falciparum with human chorionic BeWo 
cells
Aliquots containing 0.2% and 2.0% parasitaemia of 3D7,
7G8, and FVO P. falciparum-IE were added to the syncy-
tialized BeWo-ST cells, so that the IE made direct contact
with cells secreting hCG. IE were also cultured without
BeWo-ST cells. After 24 hours, co-cultures initiated with
0.2% and 2% parasitaemia contained 6,510 ± 643 and
5,875 ± 180 mIU hCG/ml, respectively; with similar levels
detected at 48 hrs (6,100 ± 473 and 3,950 ± 512 mIU
hCG/ml, respectively). The 3D7, 7H8 and FVO strains
grew at different rates, with parasitaemia increasing 2- to
3.3-fold during the first 24 hrs in cultures with and with-
out BeWo-ST cells (Figure 4A–B). Instead of enhancing
parasite growth, the parasites grew at a slightly slower rate
in co-cultures with hCG-secreting BeWo-ST cells. Parasi-
taemia continued to increase during the next 24 hrs in all
cultures except for one (7G8 strain initiated at 2% parasi-
taemia), but parasitaemia were consistently lower in the
co-cultures (Figure 4C and 4D) than in the cultures of IE
is complete parasite culture medium. Thus, there was no
evidence that parasites were stimulated to grow faster dur-
ing a 48 hr period in this co-culture system.
Discussion
A previous study reported that NF54 P. falciparum para-
sites grew faster in vitro when 8.3 and 16.7 IU hCG/ml
from Ferring were added to the cultures [7]. The response
to hCG was dose-dependent, eliminated by boiling, but
suppressive above 33 IU/ml (or as reported, 200 IU/6 ml).
In the current study, addition 12–200 IU/ml of commer-
cial hCG from three sources did not alter the growth of the
NF54-3D7 or FVO strains of P. falciparum in vitro (Figures
2 and 3). IE of the 3D7, 7G8, and FVO strains were also
co-cultured with the BeWo-ST in an attempt to replicate
conditions within the IVS where hCG is produced. Parasi-
taemia were actually lower, not enhanced, in the co-cul-
tures compared to parasitaemia in routine cultures
conducted at the same time (Figure 4). BeWo-ST secrete
many bioactive factors in addition to hCG [15]. It is
unclear if the lower parasitaemia in the co-cultured of
BeWo and IE were due to factors produced by the BeWo
cells or if culture conditions in the co-cultures were sub-
optimal for extended parasite growth due to the addition
of BeWo culture medium. Taken together, the results pro-
vide little evidence that hCG, either purified or naturally
produced, enhances the rate of parasite growth.
Additional support for the conclusion that hCG does not
enhance parasite growth comes from a search of the P. fal-
ciparum  (3D7) genome database. If malarial parasites
were able to respond to hCG, they should have a receptor
for the hormone. A nucleotide BLAST, (Basic Local Align-
ment Search Tool) search found no similarities between
the genome of P. falciparum and the luteinizing hormone/
choriogonadotropin receptor (LHCGR) (NM 000233.3 –
mRNA). Thus, this parasite does not have a receptor that
shares homology with the human receptor for hCG. A
careful search of literature also found no reports that hCG
enhances growth of any other protozoan parasite.
It is difficult to determine why results of the current study
failed to confirm those of the earlier one [7]. A diligent
attempt was made to replicate the previous study. The
most obvious difference was the source of hCG. The hCG
preparations used in this study consisted primarily of the
α and β-chains of hCG, although they could have been
contaminated with other molecules (Figure 1). Previous
studies have reported significant variation in purity and
biological activity of commercial hCG preparations
[11,12,17]. A comparative study examined hCG obtained
from Ferring (Choragon) with other commercial sources
and found that it was contaminated with a high level of
EGF [10]. An other study reported hCG from Ferring stim-
ulated CHO cells to produce cAMP, possibly due to the
presence of the nicked form of hCG [18]. The prepara-
tions used in these studies and those of Rohrig et al [7]
could be different, but it is possible that the effect on par-
asite growth they found was due to highly glycosylated or
nicked-forms of hCG or to other contaminating stimula-
tory molecule in the preparation. Recombinant hCG has
been used in clinical trials [19], but is not readily availableMalaria Journal 2009, 8:101 http://www.malariajournal.com/content/8/1/101
Page 5 of 8
(page number not for citation purposes)
Influence of hCG on parasite growth in vitro with parasitaemia determined by microscopy Figure 2
Influence of hCG on parasite growth in vitro with parasitaemia determined by microscopy. A). Geometric mean 
parasitaemia ± SE for NF54-3D7 parasites cultured with hCG from Calbiochem (3 experiments), Cell Sciences, Inc. (2 exp't) 
and Sigma Aldrich (1 exp't); results from triplicate cultures were averaged and then the means for each of the 6 expt. were 
averaged. B) FVO parasites were cultured with hCG from Calbiochem (1 exp't) and Cell Sciences (1 exp't.); results from trip-
licate wells were averaged and then the means from each experiment were averaged. The * indicates starting parasitaemia.
A. NF54-3D7 (n = 6 experiments)
0
1
2
3
4
5
6
135
Days of in vitro Culture
G
e
o
m
e
t
r
i
c
M
e
a
n
o
f
%
P
a
r
a
s
i
t
￿
￿
m
i
a
0I U / m l
12.5 IU/ml
25 IU/ml
50 IU/ml
100 IU/ml
200 IU/ml
B. FVO (n = 2 experiments)
0
1
2
3
4
5
6
135
Days of in vitro Culture
G
e
o
m
e
t
r
i
c
M
e
a
n
o
f
%
P
a
r
a
s
i
￿
￿
e
m
i
a
0I U / m l
12.5 IU/ml
25 IU/ml
50 IU/ml
100 IU/ml
200 IU/ml
*
*Malaria Journal 2009, 8:101 http://www.malariajournal.com/content/8/1/101
Page 6 of 8
(page number not for citation purposes)
Influence of hCG on parasite growth in vitro with parasitaemia determined by flow cytometry Figure 3
Influence of hCG on parasite growth in vitro with parasitaemia determined by flow cytometry. Geometric means 
for experiments in which 3D7 and FVO parasites were cultured with hCG from the three sources. Results from triplicate wells 
were averaged for cultures without hCG (dotted lines) and cultures supplemented with hCG (solid lines).
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for research purposes. Although the differences remain
unclear, the three preparations of purified hCG tested in
the current study did not enhance the growth of P. falci-
parum in vitro.
Even though hCG may not have a direct effect on IE, it
could still be important in placental malaria. The primary
role of hCG is to extend the life of the corpus luteum, most
likely by increasing endothelial cell proliferation and ves-
sel stabilization, and participate in early placental angio-
genesis [20]. Thus, hCG may have a role in creating new
blood vessels where trophozoite-stage P. falciparum IE
sequester. HCG has also been found to modulate innate
and acquired immune responses (reviewed in [21]).
Accordingly, it is possible an increase in parasite numbers
in the peripheral blood of pregnant women results from
suppression of immune responses that aid in parasite
clearance.
In summary, pregnant women are more susceptible to
malaria and have higher parasitaemia than other adults.
IE sequester in the IVS by adhesion to CSA and reach high
numbers in the placenta, especially early in pregnancy
before antibodies to var2csa are produced. At this time,
ring-stage parasites are released from the IVS into the
peripheral blood, thereby increasing peripheral parasitae-
mia. These events correspond with peak hCG levels. The
cytoadherence mechanism along with a decrease in
immune responses that control parasitaemia are sufficient
to explain why pregnant women are susceptible to higher
parasitaemia during the early part of pregnancy.
Co-culture of BeWo cells with P. falciparum-infected erythrocytes Figure 4
Co-culture of BeWo cells with P. falciparum-infected erythrocytes. Parasites were either cultured normally (alone) or 
with BeWo-ST. Parasitaemia after 24 hrs in cultures initiated with (A) 0.2% parasitaemia or (B) 2% parasitaemia. Parasitaemia 
after 48 hrs in cultures initiated with (C) 0.2% or (D) 2% parasitaemia. Results are means percent parasitaemia ± SD for tripli-
cate samples determined by flow cytometry. Horizontal lines indicate initial parasitaemia.
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Conclusion
Results from the study failed to conclusively demonstrate
a role of hCG in enhancing the growth of P. falciparum in
vitro. It is, therefore, unlikely that increased parasitaemia
found early in pregnancy is due to hCG-mediated
enhancement of parasite growth.
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